| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA | 24 | 2023 | 241 | 9.410 |
Why?
|
| Nucleic Acid Conformation | 19 | 2024 | 146 | 4.280 |
Why?
|
| RNA-Binding Proteins | 9 | 2023 | 146 | 2.330 |
Why?
|
| Computational Biology | 9 | 2024 | 293 | 1.900 |
Why?
|
| RNA, Viral | 7 | 2024 | 301 | 1.860 |
Why?
|
| Protein Interaction Mapping | 6 | 2014 | 61 | 1.800 |
Why?
|
| Sequence Analysis, RNA | 9 | 2022 | 106 | 1.490 |
Why?
|
| Databases, Genetic | 2 | 2021 | 93 | 1.380 |
Why?
|
| Animals | 46 | 2024 | 15081 | 1.250 |
Why?
|
| Software | 4 | 2021 | 217 | 1.230 |
Why?
|
| Genome, Viral | 5 | 2024 | 109 | 1.080 |
Why?
|
| DEAD-box RNA Helicases | 3 | 2023 | 13 | 1.010 |
Why?
|
| Multiprotein Complexes | 4 | 2014 | 54 | 1.010 |
Why?
|
| High-Throughput Screening Assays | 4 | 2021 | 65 | 1.000 |
Why?
|
| Models, Molecular | 13 | 2024 | 808 | 0.980 |
Why?
|
| Ribonuclease III | 2 | 2021 | 10 | 0.950 |
Why?
|
| Mice | 24 | 2024 | 5913 | 0.910 |
Why?
|
| Cell Communication | 1 | 2024 | 97 | 0.910 |
Why?
|
| Proteins | 5 | 2019 | 369 | 0.880 |
Why?
|
| Microsomes, Liver | 4 | 2010 | 70 | 0.870 |
Why?
|
| Humans | 50 | 2024 | 37093 | 0.830 |
Why?
|
| Morpholines | 3 | 2010 | 69 | 0.820 |
Why?
|
| RNA Viruses | 1 | 2021 | 22 | 0.810 |
Why?
|
| Binding Sites | 12 | 2023 | 651 | 0.770 |
Why?
|
| Ficusin | 2 | 2018 | 2 | 0.770 |
Why?
|
| Protein Binding | 10 | 2023 | 972 | 0.750 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 45 | 0.740 |
Why?
|
| Drug Discovery | 1 | 2020 | 82 | 0.700 |
Why?
|
| Algorithms | 6 | 2023 | 465 | 0.670 |
Why?
|
| Receptor, Cannabinoid, CB2 | 2 | 2010 | 32 | 0.640 |
Why?
|
| Models, Statistical | 1 | 2019 | 180 | 0.640 |
Why?
|
| RNA, Messenger | 8 | 2023 | 1207 | 0.630 |
Why?
|
| Viral Envelope Proteins | 1 | 2018 | 82 | 0.620 |
Why?
|
| Databases, Nucleic Acid | 1 | 2018 | 27 | 0.620 |
Why?
|
| Gene Expression Regulation | 9 | 2023 | 1015 | 0.580 |
Why?
|
| Proteomics | 4 | 2013 | 325 | 0.550 |
Why?
|
| Protein Conformation | 6 | 2023 | 389 | 0.540 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2016 | 40 | 0.530 |
Why?
|
| Databases, Protein | 2 | 2012 | 48 | 0.520 |
Why?
|
| Antigen-Presenting Cells | 1 | 2014 | 30 | 0.500 |
Why?
|
| Chromatin | 4 | 2022 | 169 | 0.490 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 70 | 0.490 |
Why?
|
| Protein Biosynthesis | 6 | 2023 | 133 | 0.480 |
Why?
|
| Indoles | 2 | 2006 | 158 | 0.470 |
Why?
|
| RNA Probes | 3 | 2022 | 10 | 0.450 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 312 | 0.420 |
Why?
|
| Zebrafish | 3 | 2024 | 128 | 0.420 |
Why?
|
| RNA, Double-Stranded | 3 | 2023 | 24 | 0.420 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 357 | 0.410 |
Why?
|
| Internet | 5 | 2021 | 211 | 0.400 |
Why?
|
| Signal Transduction | 7 | 2022 | 1908 | 0.400 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2013 | 42 | 0.390 |
Why?
|
| Tamoxifen | 4 | 2016 | 65 | 0.390 |
Why?
|
| Membrane Proteins | 1 | 2014 | 517 | 0.380 |
Why?
|
| Genomics | 2 | 2024 | 223 | 0.380 |
Why?
|
| Indomethacin | 1 | 2010 | 28 | 0.370 |
Why?
|
| Breast Neoplasms | 8 | 2020 | 1502 | 0.370 |
Why?
|
| Molecular Structure | 5 | 2021 | 492 | 0.350 |
Why?
|
| Gene Expression Profiling | 4 | 2024 | 626 | 0.340 |
Why?
|
| Prodrugs | 3 | 2015 | 24 | 0.330 |
Why?
|
| Ribosomal Proteins | 2 | 2019 | 21 | 0.330 |
Why?
|
| Transcription, Genetic | 4 | 2021 | 578 | 0.330 |
Why?
|
| Cryoelectron Microscopy | 3 | 2024 | 43 | 0.320 |
Why?
|
| Genome | 3 | 2024 | 125 | 0.310 |
Why?
|
| Receptors, Cannabinoid | 2 | 2004 | 26 | 0.300 |
Why?
|
| Cell Line, Tumor | 12 | 2022 | 2231 | 0.300 |
Why?
|
| Cell Line | 3 | 2021 | 1354 | 0.300 |
Why?
|
| Artificial Intelligence | 2 | 2022 | 70 | 0.300 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2016 | 222 | 0.290 |
Why?
|
| Antineoplastic Agents | 4 | 2015 | 803 | 0.270 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 120 | 0.270 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2015 | 421 | 0.270 |
Why?
|
| MicroRNAs | 3 | 2022 | 426 | 0.270 |
Why?
|
| RNA Splicing | 3 | 2024 | 40 | 0.260 |
Why?
|
| User-Computer Interface | 2 | 2018 | 62 | 0.260 |
Why?
|
| Polymerase Chain Reaction | 2 | 2018 | 448 | 0.250 |
Why?
|
| Reverse Transcription | 3 | 2023 | 18 | 0.250 |
Why?
|
| Virus Replication | 3 | 2024 | 278 | 0.250 |
Why?
|
| Ribosomes | 3 | 2023 | 32 | 0.240 |
Why?
|
| Piperidines | 1 | 2004 | 77 | 0.240 |
Why?
|
| Caenorhabditis elegans | 2 | 2023 | 78 | 0.240 |
Why?
|
| Pyrazoles | 1 | 2004 | 85 | 0.240 |
Why?
|
| Spliceosomes | 1 | 2024 | 10 | 0.240 |
Why?
|
| Mass Spectrometry | 3 | 2015 | 260 | 0.240 |
Why?
|
| Influenza A virus | 1 | 2024 | 27 | 0.230 |
Why?
|
| Codon, Initiator | 1 | 2023 | 3 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 1609 | 0.230 |
Why?
|
| Retroelements | 1 | 2023 | 13 | 0.230 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2015 | 33 | 0.230 |
Why?
|
| Substrate Specificity | 2 | 2021 | 212 | 0.230 |
Why?
|
| Base Sequence | 4 | 2018 | 997 | 0.230 |
Why?
|
| Antiviral Agents | 2 | 2021 | 157 | 0.220 |
Why?
|
| G-Quadruplexes | 1 | 2022 | 5 | 0.220 |
Why?
|
| Semen | 1 | 2023 | 51 | 0.220 |
Why?
|
| Macromolecular Substances | 1 | 2023 | 96 | 0.220 |
Why?
|
| Smad7 Protein | 1 | 2022 | 5 | 0.220 |
Why?
|
| Transposases | 1 | 2022 | 8 | 0.220 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 2 | 2020 | 4 | 0.220 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 219 | 0.220 |
Why?
|
| Influenza, Human | 1 | 2024 | 83 | 0.220 |
Why?
|
| Brain Stem Neoplasms | 1 | 2022 | 1 | 0.220 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2020 | 112 | 0.220 |
Why?
|
| Cytoskeleton | 1 | 2023 | 110 | 0.220 |
Why?
|
| Astrocytoma | 1 | 2022 | 14 | 0.210 |
Why?
|
| Naphthalenes | 1 | 2002 | 38 | 0.210 |
Why?
|
| Nucleotides | 1 | 2022 | 36 | 0.210 |
Why?
|
| Oogenesis | 1 | 2022 | 23 | 0.210 |
Why?
|
| Erythrocytes | 1 | 2023 | 111 | 0.210 |
Why?
|
| Receptors, Drug | 1 | 2002 | 58 | 0.210 |
Why?
|
| Bayes Theorem | 2 | 2012 | 94 | 0.210 |
Why?
|
| Nuclear Factor 90 Proteins | 1 | 2022 | 1 | 0.210 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2022 | 2 | 0.210 |
Why?
|
| Interferon Type I | 1 | 2022 | 18 | 0.210 |
Why?
|
| Computer Simulation | 2 | 2022 | 362 | 0.210 |
Why?
|
| Cannabinoids | 1 | 2002 | 56 | 0.200 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 61 | 0.200 |
Why?
|
| Cilia | 1 | 2021 | 27 | 0.200 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 43 | 0.200 |
Why?
|
| Drug Design | 2 | 2020 | 162 | 0.200 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2021 | 40 | 0.190 |
Why?
|
| Liver | 1 | 2004 | 479 | 0.190 |
Why?
|
| RNA, Fungal | 1 | 2021 | 8 | 0.190 |
Why?
|
| RNA Editing | 1 | 2021 | 36 | 0.190 |
Why?
|
| RNA, Plant | 1 | 2021 | 24 | 0.190 |
Why?
|
| RNA, Bacterial | 1 | 2021 | 33 | 0.190 |
Why?
|
| Disease | 1 | 2020 | 18 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2021 | 136 | 0.190 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2021 | 188 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 173 | 0.190 |
Why?
|
| Hepatitis E virus | 1 | 2020 | 2 | 0.190 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2020 | 3 | 0.180 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2020 | 29 | 0.180 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 142 | 0.180 |
Why?
|
| DNA, Complementary | 2 | 2018 | 191 | 0.180 |
Why?
|
| Viral Proteins | 1 | 2021 | 174 | 0.180 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 44 | 0.180 |
Why?
|
| Estrogens | 2 | 2013 | 202 | 0.180 |
Why?
|
| Mutation | 3 | 2020 | 1095 | 0.180 |
Why?
|
| RNA, Untranslated | 1 | 2020 | 42 | 0.180 |
Why?
|
| Embryo, Nonmammalian | 1 | 2020 | 59 | 0.180 |
Why?
|
| Doxorubicin | 1 | 2020 | 84 | 0.180 |
Why?
|
| RNA, Transfer | 1 | 2019 | 28 | 0.180 |
Why?
|
| Normal Distribution | 1 | 2019 | 14 | 0.180 |
Why?
|
| Leucine | 1 | 2019 | 29 | 0.180 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2018 | 78 | 0.170 |
Why?
|
| Monocytes | 1 | 2022 | 257 | 0.170 |
Why?
|
| Aldehydes | 1 | 2020 | 69 | 0.170 |
Why?
|
| Transcription Factors | 4 | 2022 | 681 | 0.170 |
Why?
|
| Leukemia | 1 | 2019 | 56 | 0.170 |
Why?
|
| Rats | 5 | 2010 | 3483 | 0.170 |
Why?
|
| Receptor, erbB-2 | 1 | 2020 | 133 | 0.170 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2019 | 70 | 0.170 |
Why?
|
| Cluster Analysis | 1 | 2019 | 195 | 0.170 |
Why?
|
| Vero Cells | 1 | 2018 | 93 | 0.160 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 173 | 0.160 |
Why?
|
| Stem Cells | 1 | 2019 | 141 | 0.160 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 202 | 0.160 |
Why?
|
| RNA, Transfer, Leu | 1 | 2017 | 1 | 0.160 |
Why?
|
| Hela Cells | 4 | 2022 | 366 | 0.150 |
Why?
|
| Cross-Linking Reagents | 1 | 2018 | 51 | 0.150 |
Why?
|
| Cell Proliferation | 4 | 2017 | 1198 | 0.150 |
Why?
|
| RNA Precursors | 3 | 2024 | 27 | 0.150 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2015 | 182 | 0.150 |
Why?
|
| Structure-Activity Relationship | 5 | 2014 | 409 | 0.150 |
Why?
|
| Data Mining | 1 | 2017 | 23 | 0.140 |
Why?
|
| Sterols | 1 | 2016 | 23 | 0.140 |
Why?
|
| Boronic Acids | 1 | 2016 | 19 | 0.140 |
Why?
|
| Pyridines | 2 | 2014 | 116 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 935 | 0.140 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2016 | 32 | 0.140 |
Why?
|
| Female | 13 | 2022 | 20969 | 0.140 |
Why?
|
| Genome, Insect | 1 | 2016 | 8 | 0.140 |
Why?
|
| Mitochondria | 1 | 2020 | 487 | 0.140 |
Why?
|
| ROC Curve | 2 | 2013 | 138 | 0.130 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2015 | 17 | 0.130 |
Why?
|
| Open Reading Frames | 3 | 2023 | 77 | 0.130 |
Why?
|
| Aminophenols | 1 | 2015 | 2 | 0.130 |
Why?
|
| Agaricales | 1 | 2015 | 6 | 0.130 |
Why?
|
| Cell Movement | 3 | 2014 | 571 | 0.130 |
Why?
|
| Monophenol Monooxygenase | 1 | 2015 | 14 | 0.130 |
Why?
|
| Oxazines | 1 | 2015 | 26 | 0.130 |
Why?
|
| Cell Nucleus | 3 | 2022 | 366 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 306 | 0.120 |
Why?
|
| Bibenzyls | 1 | 2014 | 4 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 767 | 0.120 |
Why?
|
| Tubulin Modulators | 1 | 2014 | 18 | 0.120 |
Why?
|
| Phylogeny | 2 | 2019 | 644 | 0.120 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 180 | 0.120 |
Why?
|
| Thiazoles | 1 | 2014 | 74 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2017 | 259 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 1371 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2014 | 399 | 0.110 |
Why?
|
| Nitriles | 1 | 2013 | 69 | 0.110 |
Why?
|
| Mesoderm | 2 | 2013 | 70 | 0.110 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2012 | 5 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 6 | 0.110 |
Why?
|
| Triazoles | 1 | 2013 | 86 | 0.110 |
Why?
|
| PPAR gamma | 1 | 2012 | 53 | 0.100 |
Why?
|
| RNA, Small Nuclear | 2 | 2024 | 10 | 0.100 |
Why?
|
| Oocytes | 2 | 2023 | 146 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2012 | 100 | 0.100 |
Why?
|
| Cadherins | 1 | 2012 | 90 | 0.100 |
Why?
|
| Bacteroides | 1 | 2012 | 8 | 0.100 |
Why?
|
| Mammals | 2 | 2022 | 105 | 0.100 |
Why?
|
| Endocrine Disruptors | 1 | 2012 | 39 | 0.100 |
Why?
|
| Proteome | 1 | 2012 | 144 | 0.100 |
Why?
|
| Ligands | 2 | 2022 | 349 | 0.100 |
Why?
|
| RNA Stability | 2 | 2021 | 26 | 0.100 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 206 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2012 | 103 | 0.090 |
Why?
|
| Estrogen Antagonists | 1 | 2010 | 28 | 0.090 |
Why?
|
| Structural Homology, Protein | 1 | 2010 | 13 | 0.090 |
Why?
|
| Systems Biology | 1 | 2010 | 22 | 0.090 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2010 | 98 | 0.090 |
Why?
|
| Bacterial Proteins | 2 | 2012 | 540 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 2010 | 119 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 628 | 0.090 |
Why?
|
| Water Pollutants, Chemical | 1 | 2012 | 164 | 0.090 |
Why?
|
| Sequence Alignment | 1 | 2010 | 265 | 0.090 |
Why?
|
| Isoflavones | 1 | 2010 | 129 | 0.090 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2008 | 4 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2008 | 8 | 0.080 |
Why?
|
| Epithelium | 1 | 2008 | 79 | 0.080 |
Why?
|
| Benzamidines | 1 | 2007 | 5 | 0.080 |
Why?
|
| Trypanosoma brucei rhodesiense | 1 | 2007 | 6 | 0.080 |
Why?
|
| Trypanosomiasis, African | 1 | 2007 | 23 | 0.080 |
Why?
|
| RNA Splice Sites | 2 | 2020 | 10 | 0.080 |
Why?
|
| Trypanocidal Agents | 1 | 2007 | 39 | 0.070 |
Why?
|
| Embryonic Stem Cells | 2 | 2020 | 59 | 0.070 |
Why?
|
| 3' Untranslated Regions | 2 | 2020 | 74 | 0.070 |
Why?
|
| Base Pairing | 2 | 2017 | 42 | 0.070 |
Why?
|
| Piperazines | 1 | 2007 | 111 | 0.070 |
Why?
|
| Cell Survival | 3 | 2017 | 864 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 356 | 0.070 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2007 | 83 | 0.070 |
Why?
|
| Biological Availability | 2 | 2016 | 88 | 0.070 |
Why?
|
| DNA | 2 | 2019 | 574 | 0.070 |
Why?
|
| Protein Structure, Quaternary | 2 | 2018 | 64 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 562 | 0.060 |
Why?
|
| Brain | 1 | 2012 | 1346 | 0.060 |
Why?
|
| Chick Embryo | 2 | 2014 | 74 | 0.060 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2024 | 2 | 0.060 |
Why?
|
| Phenotype | 2 | 2021 | 689 | 0.060 |
Why?
|
| DNA Cleavage | 1 | 2023 | 2 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 289 | 0.060 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2023 | 18 | 0.060 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 132 | 0.060 |
Why?
|
| Spectrin | 1 | 2023 | 5 | 0.060 |
Why?
|
| Sperm Motility | 1 | 2023 | 38 | 0.060 |
Why?
|
| Fertilization | 1 | 2023 | 38 | 0.060 |
Why?
|
| Estrogen Receptor alpha | 2 | 2016 | 111 | 0.060 |
Why?
|
| Male | 5 | 2023 | 20025 | 0.060 |
Why?
|
| Activins | 1 | 2022 | 7 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 251 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2024 | 163 | 0.050 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2022 | 23 | 0.050 |
Why?
|
| Benzoxazines | 1 | 2002 | 46 | 0.050 |
Why?
|
| Swine | 1 | 2023 | 184 | 0.050 |
Why?
|
| Actins | 1 | 2023 | 148 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2016 | 435 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2024 | 186 | 0.050 |
Why?
|
| Arabidopsis | 1 | 2023 | 95 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2015 | 337 | 0.050 |
Why?
|
| Interleukin-7 | 1 | 2022 | 7 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2016 | 224 | 0.050 |
Why?
|
| RNA, Helminth | 1 | 2021 | 4 | 0.050 |
Why?
|
| RNA, Antisense | 1 | 2021 | 17 | 0.050 |
Why?
|
| Spermatogenesis | 1 | 2023 | 155 | 0.050 |
Why?
|
| Adenosine Deaminase | 1 | 2021 | 20 | 0.050 |
Why?
|
| Containment of Biohazards | 1 | 2021 | 1 | 0.050 |
Why?
|
| Spermatozoa | 1 | 2023 | 200 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 197 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2013 | 213 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 307 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2021 | 444 | 0.050 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 2020 | 4 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2020 | 13 | 0.050 |
Why?
|
| Butanones | 1 | 2020 | 5 | 0.050 |
Why?
|
| Replication Protein A | 1 | 2020 | 8 | 0.050 |
Why?
|
| RNA Polymerase II | 1 | 2020 | 29 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 84 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2020 | 89 | 0.040 |
Why?
|
| Guanine | 1 | 2020 | 45 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2020 | 47 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 61 | 0.040 |
Why?
|
| Liposomes | 1 | 2020 | 118 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2022 | 587 | 0.040 |
Why?
|
| Protein Transport | 1 | 2020 | 302 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 539 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2013 | 859 | 0.040 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2018 | 1 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 661 | 0.040 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2018 | 53 | 0.040 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2017 | 9 | 0.040 |
Why?
|
| Ribosome Subunits, Small, Eukaryotic | 1 | 2017 | 4 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2017 | 39 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2017 | 35 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2013 | 807 | 0.040 |
Why?
|
| Inflammation | 1 | 2022 | 618 | 0.040 |
Why?
|
| Gene Expression | 1 | 2020 | 674 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2017 | 59 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 515 | 0.040 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2016 | 8 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2016 | 167 | 0.030 |
Why?
|
| Nanoparticles | 1 | 2020 | 318 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 145 | 0.030 |
Why?
|
| Acylation | 1 | 2015 | 10 | 0.030 |
Why?
|
| Cyclization | 1 | 2015 | 48 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 29 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 83 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 77 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 134 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 190 | 0.030 |
Why?
|
| Adenosine | 1 | 2015 | 59 | 0.030 |
Why?
|
| Chorioallantoic Membrane | 1 | 2014 | 11 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 91 | 0.030 |
Why?
|
| Colchicine | 1 | 2014 | 15 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 151 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2014 | 47 | 0.030 |
Why?
|
| Laminin | 1 | 2014 | 61 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 69 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 98 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 113 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2016 | 171 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 59 | 0.030 |
Why?
|
| Oxygen | 1 | 2015 | 207 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 73 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 431 | 0.030 |
Why?
|
| Point Mutation | 1 | 2014 | 93 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 91 | 0.030 |
Why?
|
| Tubulin | 1 | 2014 | 88 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 62 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 708 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 172 | 0.030 |
Why?
|
| Cell Shape | 1 | 2013 | 35 | 0.030 |
Why?
|
| rho-Associated Kinases | 1 | 2013 | 31 | 0.030 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 30 | 0.030 |
Why?
|
| Vimentin | 1 | 2013 | 37 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2013 | 58 | 0.030 |
Why?
|
| Genome, Human | 1 | 2014 | 135 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 219 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2013 | 216 | 0.030 |
Why?
|
| Amides | 1 | 2013 | 68 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 122 | 0.030 |
Why?
|
| Ethinyl Estradiol | 1 | 2012 | 9 | 0.030 |
Why?
|
| New Orleans | 1 | 2012 | 13 | 0.030 |
Why?
|
| Water Pollution, Chemical | 1 | 2012 | 10 | 0.030 |
Why?
|
| Helix-Turn-Helix Motifs | 1 | 2012 | 2 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2014 | 305 | 0.030 |
Why?
|
| Histones | 1 | 2013 | 190 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1039 | 0.030 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2012 | 19 | 0.030 |
Why?
|
| Geologic Sediments | 1 | 2012 | 42 | 0.030 |
Why?
|
| Seawater | 1 | 2012 | 45 | 0.030 |
Why?
|
| Fresh Water | 1 | 2012 | 48 | 0.030 |
Why?
|
| Mississippi | 1 | 2012 | 122 | 0.030 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 43 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 76 | 0.030 |
Why?
|
| Pesticides | 1 | 2012 | 52 | 0.030 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2012 | 43 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2012 | 84 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 229 | 0.020 |
Why?
|
| Phenols | 1 | 2012 | 80 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 1742 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2013 | 249 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 156 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2013 | 387 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 408 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 56 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2010 | 81 | 0.020 |
Why?
|
| Apoptosis | 1 | 2017 | 1398 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2008 | 21 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 189 | 0.020 |
Why?
|
| Estradiol | 1 | 2010 | 262 | 0.020 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2007 | 14 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2008 | 142 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2007 | 99 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 623 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 409 | 0.020 |
Why?
|
| Child | 1 | 2014 | 3131 | 0.020 |
Why?
|